Singapore – Singapore General Hospital and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that they will work together to establish the Singapore General Hospital Digital and Computational Pathology Center of Excellence. The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying artificial intelligence (AI) to increase productivity and enhance patient care.
Located within SGH’s Division of Pathology, one of the largest pathology laboratories in ASEAN, the Center of Excellence aims to establish ASEAN’s first fully digitised histopathology laboratory by expanding its digital pathology capabilities for primary diagnosis, training, and R&D with the Philips IntelliSite Pathology Solution. Both SGH and Philips will also work closely on other diverse areas, including streamlining of the histopathology laboratory’s digital workflow.
A recent study, conducted by SGH and Philips, revealed that full digitization of SGH’s histopathology laboratory with the Philips IntelliSite Pathology Solution has the potential to save over 12,000 hours every year.
Through optimisation of digital pathology at SGH, the hospital will be able to further its research in AI. AI-based tools can aid pathologists in diagnosing diseases such as cancer, which is the leading cause of mortality in Singapore, and empower them to face the current challenges in pathology. The increasing number of cancer cases, an aging population, and rapid advances in personalized medicine have resulted in significant increases in the complexity of pathological diagnostics and the workload of pathologists. AI will allow pathologists to focus more on challenging tasks and unusual cases that require a higher degree of expertise and skills."We have always attempted to transform our processes and capabilities in anticipation of evolving circumstances and the needs of our patients. As healthcare becomes more complex and demanding, digitisation has become a key enabler for the Hospital to provide better care for our patients and to be more efficient," said Prof. Kenneth Kwek, Chief Executive Officer at SGH. "Digital pathology is an example and our partnership with companies such as Philips with the clinical and technical know-how is important in helping us achieve our goal."
"Digital pathology will enhance the quality and efficiency of a histopathology laboratory," said Diederik Zeven, General Manager, Health Systems, Philips ASEAN Pacific. "We are committed to partnering with leading healthcare institutions like Singapore General Hospital to bring the latest in precision diagnoses and AI capabilities to help them augment clinical quality, improving patient outcomes and thereby reducing the cost of care."
Philips IntelliSite Pathology Solution enables pathologists to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue samples. This technology replaces the need for traditional glass slides to be viewed under a microscope, and facilitates referencing and storage. Ultimately, digital images allow the application of computer-aided image analysis with AI. For further information, please contact:
Carol AngManager, CommunicationsSingapore General HospitalEmail: Carol.Ang@sgh.com.sg
Sheo S. Rai
Senior Manager, Brand and CommunicationsPhilips ASEAN PacificEmail: SheoShanker.Rai@philips.com
Subcribe to our mailing list to get the latest education updates.